The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial
Open accessAbstract
Background We investigated the efficacy and cost-effectiveness of five antimicrobial regimens for mild to moderate facial acne and whether propionibacterial antibiotic resistance affects treatment response. Methods In this randomised, observer-masked trial, 649 community participants were allocated one of five antibacterial regimens. Primary outcomes were patients' self-assessed improvement and reduction in inflamed lesions at 18 weeks. Analyses were by intention to treat. Findings Moderate or greater improvement at 18 weeks was reported in 72 (55%) of 131 participants assigned oral oxytetracycline plus topical placebo, 70 (54%) of 130 assigned oral minocycline plus topical placebo, 78 (60%) of 130 assigned topical benzoyl peroxide plus oral placebo, 84 (66%) of 127 assigned topical erythromycin and benzoyl peroxide in a combined formulation plus oral placebo, and 82 (63%) of 131 assigned topical erythromycin and benzoyl peroxide separately plus oral placebo. Most improvement occurred in the first 6 weeks. Treatment differences for the proportion of people with at least moderate improvement were: minocycline versus oxytetracycline -1.2% (unadjusted 95% CI -13.3 to 10.9); combined erythromycin and benzoyl peroxide versus oxytetracycline 11.1% (-0.7 to 22.9) and versus minocycline 12.3% (0.4 to 24.2); erythromycin and benzoyl peroxide separately versus combined formulation -3.5% (-15.2 to 8.2); benzoyl peroxide versus oxytetracycline 5.0% (-7.0 to 17.0), versus minocycline 6.2%…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, oral minocycline monotherapy is not superior to topical BP 5% or erythromycin 2%/BP 5% in mild to moderate acne in 1 RCT”
From Guidelines of care for the management of acne vulgaris (2024) · cites this paper as [191]
Citations
Cites
Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use
FINLAY, A. Y., & KHAN, G. K. (1994) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1994.tb01167.x · Cited by 5,586
The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?
Garratt, A. M., Ruta, D. A., Abdalla, M. I., Buckingham, J. K., & Russell, I. T. (1993) · BMJ · doi:10.1136/bmj.306.6890.1440 · Cited by 1,141
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use
LEWIS-JONES, M. S., & FINLAY, A. Y. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16953.x · Cited by 1,051
Gollnick, H., Cunliffe, W., Berson, D., Dreno, B., Finlay, A., Leyden, J. J., Shalita, A. R., & Thiboutot, D. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.618 · Cited by 817
Self-citationInflammatory Events Are Involved in Acne Lesion Initiation
Jeremy, A. H. T., Holland, D. B., Roberts, S. G., Thomson, K. F., & Cunliffe, W. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12321.x · Cited by 541
Self-citationThe assessment of acne vulgaris—the Leeds technique
BURKE, B. M., & CUNLIFFE, W. J. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04020.x · Cited by 376
Self-citationAntibiotic-resistant acne: lessons from Europe
Ross, J. I., Snelling, A. M., Carnegie, E., Coates, P., Cunliffe, W. J., Bettoli, V., Tosti, G., Katsambas, A., Galvan Perez Del Pulgar, J. I., Rollman, O., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05067.x · Cited by 360
Self-citationEADY, E. A., COVE, J. H., HOLLAND, K. T., & CUNLIFFE, W. J. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01399.x · Cited by 279
Self-citationCurrent Concepts of the Pathogenesis of Acne: Implications for Drug Treatment
Gollnick, H. (2003) · Drugs · doi:10.2165/00003495-200363150-00005 · Cited by 230
Propionibacterium acnes resistance to antibiotics in acne patients
Leyden, J. J., McGinley, K. J., Cavalieri, S., Webster, G. F., Mills, O. H., & Kligman, A. M. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70005-8 · Cited by 221
Cited by
Williams, H. C., Dellavalle, R. P., & Garner, S. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60321-8 · Cited by 1,126
Self-citationBhate, K., & Williams, H. C. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12149 · Cited by 890
Self-citationThiboutot, D., Gollnick, H., Bettoli, V., Dréno, B., Kang, S., Leyden, J. J., Shalita, A. R., Lozada, V. T., Berson, D., Finlay, A., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.01.019 · Cited by 843
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
European Evidence‐based (S3) Guidelines for the Treatment of Acne
Nast, A., Dréno, B., Bettoli, V., Degitz, K., Erdmann, R., Finlay, A. Y., Ganceviciene, R., Haedersdal, M., Layton, A., López‐Estebaranz, J. L., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04374.x · Cited by 426
Metadata
- Authors
- Ozolins, M., Eady, E. A., Avery, A. J., Cunliffe, W. J., Li Wan Po, A., O'Neill, C., Simpson, N. B., Walters, C. E., Carnegie, E., Lewis, J. B., Dada, J., Haynes, M., Williams, K., & Williams, H. C.
- Affiliations
- Queen's Medical Centre (GB)
- University of Leeds (GB)
- University of Nottingham (GB)
- Leeds General Infirmary (GB)
- Royal Victoria Infirmary (GB)
- Corresponding author
- Williams, Hywel C
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 364
- Issue
- 9452
- Pages
- 2188-2195
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2111319723
- Cited by
- 168
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2022: 8 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 8
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Aston Publications Explorer (Aston University) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Health Technology Assessment Programme
- Topics
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- acne, benzoyl peroxide, erythromycin, oxytetracycline, minocycline, tetracycline resistance, propionibacteria, cost-effectiveness, community-based treatment, treatment response
- MeSH terms
- Acne Vulgaris, Administration, Oral, Administration, Topical, Adolescent, Adult, Anti-Bacterial Agents, Benzoyl Peroxide, Child, Cost-Benefit Analysis, Erythromycin, Facial Dermatoses, Female, Humans, Male, Minocycline, Oxytetracycline, Skin, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)17591-0
- The paper
- Ozolins, M., Eady, E. A., Avery, A. J., Cunliffe, W. J., Li Wan Po, A., O'Neill, C., Simpson, N. B., Walters, C. E., Carnegie, E., Lewis, J. B., Dada, J., Haynes, M., Williams, K., & Williams, H. C. (2004). Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)17591-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.